Laurie Musial

457 total citations
8 papers, 350 citations indexed

About

Laurie Musial is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Laurie Musial has authored 8 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Laurie Musial's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). Laurie Musial is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). Laurie Musial collaborates with scholars based in United States, Canada and Germany. Laurie Musial's co-authors include Asher Chanan‐Khan, Kena C. Miller, Alice Mohr, Zale P. Bernstein, Myron S. Czuczman, Swaminathan P. Iyer, David Spaner, Kenichi Takeshita, Catriona Byrne and David Lawrence and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia & lymphoma.

In The Last Decade

Laurie Musial

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurie Musial United States	5	265	219	135	104	93	8	350
Rose Mantel United States	8	254 1.0×	193 0.9×	98 0.7×	112 1.1×	76 0.8×	13	327
Polina Kaplan Poland	6	283 1.1×	228 1.0×	116 0.9×	58 0.6×	94 1.0×	9	331
Gracy Zacharian United States	4	325 1.2×	288 1.3×	107 0.8×	32 0.3×	124 1.3×	5	343
Binsah George United States	4	257 1.0×	192 0.9×	106 0.8×	40 0.4×	85 0.9×	8	294
Francesca Yates United Kingdom	6	260 1.0×	204 0.9×	94 0.7×	38 0.4×	88 0.9×	11	278
Richard F Schlenk Germany	5	312 1.2×	252 1.2×	62 0.5×	37 0.4×	159 1.7×	5	368
Laura Wake United States	5	221 0.8×	186 0.8×	51 0.4×	38 0.4×	102 1.1×	17	270
Geisler Ch Denmark	5	357 1.3×	291 1.3×	73 0.5×	52 0.5×	186 2.0×	6	388
Josie Montegaard United States	9	205 0.8×	168 0.8×	65 0.5×	36 0.3×	66 0.7×	15	232
Athanassios Zomas Greece	5	287 1.1×	248 1.1×	116 0.9×	33 0.3×	121 1.3×	6	355

Countries citing papers authored by Laurie Musial

Since Specialization

Citations

This map shows the geographic impact of Laurie Musial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Musial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Musial more than expected).

Fields of papers citing papers by Laurie Musial

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Musial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Musial. The network helps show where Laurie Musial may publish in the future.

Co-authorship network of co-authors of Laurie Musial

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Musial. A scholar is included among the top collaborators of Laurie Musial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Musial. Laurie Musial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Miller, Kena C., et al.. (2010). Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide. Clinical journal of oncology nursing. 14(4). 491–499. 6 indexed citations

Chanan‐Khan, Asher, Kena C. Miller, Laurie Musial, et al.. (2009). Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial. Leukemia & lymphoma. 50(7). 1096–1101. 17 indexed citations

Chanan‐Khan, Asher, Kena C. Miller, Laurie Musial, et al.. (2006). Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study. Journal of Clinical Oncology. 24(34). 5343–5349. 314 indexed citations

Musial, Laurie, Kena C. Miller, Rami Manochakian, et al.. (2006). Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.. Blood. 108(11). 4987–4987. 4 indexed citations

Manochakian, Rami, et al.. (2006). Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.. Blood. 108(11). 5057–5057. 1 indexed citations

Musial, Laurie, et al.. (2006). Prednisone (P) prophylaxis decreases incidence and severity of lenalidomide (L) induced flare reaction (flr) in patients with relapse (rel) or refractory (ref) chronic lymphocytic leukemia. Journal of Clinical Oncology. 24(18_suppl). 18512–18512. 2 indexed citations

Chanan‐Khan, Asher, Kena C. Miller, Laurie Musial, et al.. (2006). Clinical Efficacy of Lenalidomide {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of a Phase II Clinical Trial.. Blood. 108(11). 306–306. 5 indexed citations

Miller, Kena C., et al.. (2006). Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).. Blood. 108(11). 4101–4101. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact